Voglibose
- Generic Name
- Voglibose
- Drug Type
- Small Molecule
- Chemical Formula
- C10H21NO7
- CAS Number
- 83480-29-9
- Unique Ingredient Identifier
- S77P977AG8
Overview
Voglibose is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. It is made in India by Ranbaxy Labs and sold under the trade name Volix.
Background
Voglibose is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. It is made in India by Ranbaxy Labs and sold under the trade name Volix.
Indication
For the treatment of diabetes. It is specifically used for lowering post-prandial blood glucose levels thereby reducing the risk of macrovascular complications.
Associated Conditions
- Hyperglycemia, Postprandial
- Type 1 Diabetes Mellitus
- Type 2 Diabetes Mellitus
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath